BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12927670)

  • 1. Stent therapy for malignant superior vena cava syndrome: should be first line therapy or simple adjunct to radiotherapy.
    Chatziioannou A; Alexopoulos T; Mourikis D; Dardoufas K; Katsenis K; Lazarou S; Koutoulidis V; Ladopoulos Ch; Vlachos L
    Eur J Radiol; 2003 Sep; 47(3):247-50. PubMed ID: 12927670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endovascular stenting for end-stage lung cancer patients with superior vena cava syndrome post first-line treatments - A single-center experience and literature review.
    Kuo TT; Chen PL; Shih CC; Chen IM
    J Chin Med Assoc; 2017 Aug; 80(8):482-486. PubMed ID: 28501315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brachiocephalic-superior vena cava metallic stenting in malignant superior vena cava obstruction.
    Lau KY; Tan LT; Wong WW; Lee AS
    Ann Acad Med Singap; 2003 Jul; 32(4):461-5. PubMed ID: 12968550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endovascular stenting as a first choice for the palliation of superior vena cava syndrome.
    Kim YI; Kim KS; Ko YC; Park CM; Lim SC; Kim YC; Park KO; Yoon W; Kim YH; Kim JK; Ahn SJ
    J Korean Med Sci; 2004 Aug; 19(4):519-22. PubMed ID: 15308841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stent placement for the treatment of malignant superior vena cava syndrome - a single-center series of 56 patients.
    Sobrinho G; Aguiar P
    Arch Bronconeumol; 2014 Apr; 50(4):135-40. PubMed ID: 24360084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Effectiveness of Abre Self-Expanding Venous Stent for Treatment of Superior Vena Cava Syndrome.
    An TJ; McNamara SL; Ardestani A; Zurkiya O; Cahalane A; Stecker MS; Epelboym Y; Burch E; Desai K; Kalva SP
    Vasc Endovascular Surg; 2024 Aug; 58(6):617-622. PubMed ID: 38670555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal pericardial tamponade after superior vena cava stenting.
    Ploegmakers MJ; Rutten MJ
    Cardiovasc Intervent Radiol; 2009 May; 32(3):585-9. PubMed ID: 18855048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fast-track management of malignant superior vena cava syndrome.
    Lee-Elliott CE; Abubacker MZ; Lopez AJ
    Cardiovasc Intervent Radiol; 2004; 27(5):470-3. PubMed ID: 15383849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome.
    Lanciego C; Pangua C; Chacón JI; Velasco J; Boy RC; Viana A; Cerezo S; García LG
    AJR Am J Roentgenol; 2009 Aug; 193(2):549-58. PubMed ID: 19620456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covered stent placement for the treatment of malignant superior vena cava syndrome: is unilateral covered stenting safe and effective?
    Cho Y; Gwon DI; Ko GY; Ko HK; Kim JH; Shin JH; Yoon HK; Sung KB
    Korean J Radiol; 2014; 15(1):87-94. PubMed ID: 24497797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endovascular Management of SVC Syndrome due to Fibrosing Mediastinitis-A Feasibility and Safety Analysis.
    Majumdar S; Shoela R; Kim DJ; Ramaswamy R; Mani N; Salter A; Akinwande O
    Vasc Endovascular Surg; 2018 Apr; 52(3):202-206. PubMed ID: 29433409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stenting as first option for endovascular treatment of malignant superior vena cava syndrome.
    Lanciego C; Chacón JL; Julián A; Andrade J; López L; Martinez B; Cruz M; García-García L
    AJR Am J Roentgenol; 2001 Sep; 177(3):585-93. PubMed ID: 11517051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous endovascular Y-stenting of a malignant superior vena cava and innominate vein obstruction.
    Cordial R; Moussavian MR; Corvalan J; Görtz H; Teßarek J
    Vasc Endovascular Surg; 2014 Jan; 48(1):77-9. PubMed ID: 24122722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter stenting of superior vena cava obstruction after pediatric heart transplantation: A single-center experience assessing risk factors and outcomes.
    Salavitabar A; Flyer JN; Torres AJ; Richmond ME; Crystal MA; Turner ME; Chai P; Zuckerman WA
    Pediatr Transplant; 2018 Nov; 22(7):e13267. PubMed ID: 29992703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Superior vena cava syndrome successfully controlled by metallic stent insertion].
    Sakaguchi Y; Kono T; Terada Y; Noda H
    Kyobu Geka; 2009 Jun; 62(6):460-3. PubMed ID: 19522205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of superior vena cava obstruction secondary to pacemaker wires with balloon venoplasty and insertion of metallic stents.
    Teo N; Sabharwal T; Rowland E; Curry P; Adam A
    Eur Heart J; 2002 Sep; 23(18):1465-70. PubMed ID: 12208227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of malignant obstruction of the superior vena cava with the self-expanding Wallstent.
    Stock KW; Jacob AL; Proske M; Bolliger CT; Rochlitz C; Steinbrich W
    Thorax; 1995 Nov; 50(11):1151-6. PubMed ID: 8553270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endovascular stenting in superior vena cava syndrome: utility of a through-and-through guidewire technique.
    Clark TW
    Can Assoc Radiol J; 2000 Aug; 51(4):254-9. PubMed ID: 10976248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endovascular stenting in the management of malignant superior vena cava obstruction: comparing safety, effectiveness, and outcomes between primary stenting and salvage stenting.
    Leung ST; Sung TH; Wan AY; Leung KW; Kan WK
    Hong Kong Med J; 2015 Oct; 21(5):426-34. PubMed ID: 26139689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of self-expanding vascular stent in superior vena cava syndrome for advanced tumours.
    Irace L; Martinelli O; Gattuso R; Mingoli A; Fiori E; Alunno A; Di Girolamo A; Crocetti D; Sapienza P
    Ann R Coll Surg Engl; 2021 Apr; 103(4):296-301. PubMed ID: 33682470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.